Skip to content
Kaiser Permanente joins late-stage COVID-19 vaccine study

Kaiser Permanente joins late-stage COVID-19 vaccine study

...clinical trial to test an investigational vaccine against SARS-CoV-2, the virus causing the current COVID-19 global pandemic. Kaiser Permanente plans to enroll approximately 1,400 participants at 4 sites in California...

Article

Back To Top